Add-On Treatment with Gliclazide for Cancer Patients with Type 2 Diabetes Undergoing Cyclic Glucocorticoid-Containing Chemotherapy

Add-On Treatment with Gliclazide for Cancer Patients with Type 2 Diabetes Undergoing Cyclic Glucocorticoid-Containing Chemotherapy

<b>Aims</b>: Despite its high prevalence, studies on glucocorticoid-induced hyperglycemia are lacking. We examined the glucose profiles of patients with type 2 diabetes undergoing dexamethasone-containing chemotherapy using continuous glucose monitoring (CGM). We also investigated the ef...

Full description

Saved in:
Bibliographic Details
Main Authors: Seung Eun Lee, Ju-Hyun Park, Dalyong Kim, Hyun-A Lee, Yun Seong Kang, Young Soon Yoon, Yun Jeong Jeong, Han Seok Choi, Kyoung-Ah Kim
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Biomedicines
Subjects:
diabetes
cancer
chemotherapy
dexamethasone
continuous glucose monitoring
hyperglycemia
Online Access:https://www.mdpi.com/2227-9059/13/5/1101
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2227-9059/13/5/1101

Similar Items